Smartest Technologies
SmartTest offers painless, automated capillary blood testing, starting with glucose for home diagnos
Company Overview
Snapshot
Founded in April 2023 by David Weintraub,, Smartest Technologies operates with 1–10 employees. The company has raised $500,000 across one funding round. In April 2024, Smartest Technologies secured seed funding.
Business overview
Smartest Technologies is an early-stage company developing a comprehensive digital health platform for at-home blood testing, initially focusing on glucose monitoring for the prediabetes market. Its core product, Smart-AE, is an automated, wireless glucose testing device designed for painless, accurate, and real-time results. The platform integrates with a mobile app for data transmission, personalized health insights, and remote monitoring, bridging home diagnostics with professional medical support. While launching with glucose monitoring, Smartest Technologies plans to expand its platform to include tests for lactate, cholesterol, and infectious diseases, serving the Health Tech & Life Sciences sector, particularly in Medical Devices and Medical Monitors.
Log in to access full profile ›Company Intelligence Q&A
- What is Smartest Technologies' primary focus?
- Smartest Technologies is developing a comprehensive digital health platform for at-home blood testing, initially concentrating on glucose monitoring for the prediabetes market.
- What is the Smart-AE device?
- Smart-AE is Smartest Technologies' automated, wireless glucose testing device, designed to provide painless, accurate, and real-time results for at-home use.
- When was Smartest Technologies founded?
- Smartest Technologies was founded in April 2023.
- What is the total capital raised by Smartest Technologies?
- Smartest Technologies has raised a total of $500,000.
- What is the current status of Smartest Technologies?
- Smartest Technologies is currently non-active, having ceased to operate in August 2026.